Key stats
- Market cap
- 190B
- Open
- —
- Day range
- —
- 52-week range
- $81.97 – $132.03
- Volume
- 153K
- Avg volume
- 9.92M
Q3 FY26Miss
Expected$1.43
Actual$1.42
ABT
Abbott Laboratories$109.80-$0.36-0.32%Price as of Nov 3, 2026, 9:34 AM ET
Earnings
Q2 FY26
Actual$0.53
Q1 FY26
Actual$0.61
Q4 FY25
Actual$1.03
About
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
- Employees
- 115,000
- Headquarters
- Abbott Park, IL